From January 1, 2024 to March 31, 2024, the company has repurchased 729,679 shares, representing 0.99% for $266.97 million. With this, the company has completed the repurchase of 1,995,340 shares, representing 2.7% for $705.31 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
328.6 USD | +2.04% | -2.27% | -6.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.67% | 23.94B | |
-3.18% | 185B | |
-2.68% | 105B | |
-2.23% | 68.9B | |
-6.46% | 46.16B | |
+5.33% | 40.75B | |
+20.09% | 31.11B | |
+11.32% | 24.26B | |
-12.70% | 21.86B | |
-0.25% | 21.68B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.